{"abstract":"The Food and Drug Administration (FDA) is correcting a notice of proposed rulemaking that appeared in the Federal Register of April 22, 1996 (61 FR 17807). The document proposed to amend the general labeling provisions for over-the-counter (OTC) drug products intended for oral ingestion to require the content per dosage unit and warning labeling when the product contains certain levels of calcium, magnesium, or potassium. The document was published with some errors. This document corrects those errors. DATES: Written comments by July 22, 1996. Written comments on the agency's economic impact determination by July 22, 1996. The agency is proposing that any final rule based on this proposal be effective 12 months after the date of its publication in the Federal Register. FOR FURTHER INFORMATION CONTACT: William E. Gilbertson, Center for Drug Evaluation and Research (HFD-105),- Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-2304. In FR Doc. 96-9734, appearing on page 17807 in the Federal Register of Monday, April 22, 1996, the following corrections are made: 1. On page 17808, in the third column, in the third full paragraph, in the seventh line, ``vitamin E'' is corrected to read ``vitamin A.'' 2. On page 17809, in the first column, in the first full paragraph, in the second line, ``vitamin E'' is corrected to read ``vitamin A,'' and in the same paragraph, beginning in the twelfth line, the two last sentences are removed and a new sentence is added to read ``Thus, for foods containing less than 20 mg of calcium or less than 8 mg of magnesium per serving, the content may be declared as zero or as less than 2 percent of the Daily Value, except that magnesium need not be declared unless a claim is made about the nutrient.'' 3. On page 17809, in the first column, in the third full paragraph, in the eleventh line, after the word ``amount.'', the following sentence is added: ``In the Federal Register of December 21, 1995 (60 FR 66206), FDA published a proposal entitled `Food Labeling: Nutrient Content Claims, General Principles; Health Claims, General Requirements and Other Specific Requirements for Individual Health Claims' that would revise this requirement. (See 60 FR 66206 at 66225.) Comments on the revision will be addressed in that rulemaking proceeding.''","action":"Notice of proposed rulemaking; correction.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/1996/08/19/96-21049.html","cfr_references":[{"chapter":null,"citation_url":null,"part":201,"title":21},{"chapter":null,"citation_url":null,"part":331,"title":21}],"citation":"61 FR 42826","comment_url":null,"comments_close_on":"1996-07-22","correction_of":null,"corrections":[],"dates":"Written comments by July 22, 1996. Written comments on the agency's economic impact determination by July 22, 1996. The agency is proposing that any final rule based on this proposal be effective 12 months after the date of its publication in the Federal Register.","disposition_notes":null,"docket_ids":["Docket No. 95N-0254"],"dockets":[],"document_number":"96-21049","effective_on":null,"end_page":42827,"executive_order_notes":null,"executive_order_number":null,"explanation":null,"full_text_xml_url":null,"html_url":"https://www.federalregister.gov/documents/1996/08/19/96-21049/labeling-of-orally-ingested-over-the-counter-drug-products-containing-calcium-magnesium-and","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/96-21049?publication_date=1996-08-19","mods_url":"https://www.govinfo.gov/metadata/granule/FR-1996-08-19/96-21049/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":9,"last_updated":"2026-04-04 08:15:04 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-1996-08-19/pdf/96-21049.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":null,"publication_date":"1996-08-19","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/1996/08/19/96-21049.txt","regulation_id_number_info":{"0910-AA63":{"issue":"199510","html_url":"https://www.federalregister.gov/regulations/0910-AA63/otc-drug-labeling-review","title":"OTC Drug Labeling Review","xml_url":"http://www.reginfo.gov/public/do/eAgendaViewRule?pubId=199510&RIN=0910-AA63&operation=OPERATION_EXPORT_XML","priority_category":"Substantive, Nonsignificant"}},"regulation_id_numbers":["0910-AA63"],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2011-09-21T07:48:32Z"},"regulations_dot_gov_url":null,"significant":false,"signing_date":null,"start_page":42826,"subtype":null,"title":"Labeling of Orally Ingested Over-the-Counter Drug Products Containing Calcium, Magnesium, and Potassium; Correction","toc_doc":null,"toc_subject":null,"topics":[],"type":"Proposed Rule","volume":61}